Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.

The paper describes how a second HPV-positive primary, reported in about 7.4% of people with HPV-positive head and neck cancer, can confound circulating tumor HPV DNA monitoring.

Head & NeckPubMed 37080924DOI 10.1002/hed.27378